Does Dr. ARTHUR ITKIN have financial conflicts of interest?

Dr. ARTHUR ITKIN (M.D.) has received a total of $406,601 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $406,601 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ARTHUR ITKIN?

According to CMS Open Payments data, Dr. ARTHUR ITKIN received funding from ABBVIE ($126,956), MALLINCKRODT HOSPITAL PRODUCTS ($58,662), and GENZYME CORPORATION ($55,553).

Does Dr. ARTHUR ITKIN receive research grants or speaking fees?

Dr. ARTHUR ITKIN has received $406,601 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ARTHUR ITKIN

M.D.Real-Time Hydrated

Specialty: Psychiatry & Neurology, Neurology

Practice Location: PALOS HEIGHTS, IL 60463

NPI Number: 1184634974

LIFETIME INDUSTRY VALUE

$406,601

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ITKIN is a verified Psychiatry & Neurology, Neurology practitioner based in PALOS HEIGHTS, IL.

Between 2021 and 2025, Dr. ITKIN had an overall industry promotional and research financial footprint of $406,601 as recorded in the federal CMS Open Payments database.

$406,601 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ITKIN's primary funding source is ABBVIE, which accounts for $126,956 (representing 31.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$126,956

31.2%

MALLINCKRODT HOSPITAL PRODUCTS

Rank 2

$58,662

14.4%

GENZYME CORPORATION

Rank 3

$55,553

13.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.